Victor Roy, MD, PhD

Assistant Professor, Family Medicine

Victor Roy
617.414.4465

Biography

Originally from New Jersey, Dr. Roy earned his undergraduate degree in political science from Northwestern University. During and after college, he co-founded and served as Executive Director of GlobeMed, a global network of undergraduate students and community organizations working together to tackle challenges of poverty and poor health. Alongside his medical training at Northwestern’s Feinberg School of Medicine, he pursued master’s and doctoral degrees in sociology from the University of Cambridge as a Gates Cambridge scholar. His research focused on the social and structural determinants of health, and his doctoral thesis investigated the political economy of drug development and treatment access for patients with hepatitis C. He was inspired to pursue family medicine in part by his grandfather who was a rural family physician in India. In his free time, he loves spending time with his partner Maya, diving into books, getting outdoors, and keeping up with his favorite sports teams.

Education

  • Northwestern University Medical School, MD
  • University of Cambridge, PhD
  • University of Cambridge, MPhil
  • Northwestern University, BA

Classes Taught

Publications

  • Published on 3/1/2023

    Roy V. Financing covid-19 mRNA vaccines. BMJ. 2023 Mar 01; 380:413. PMID: 36858438.

    Read at: PubMed
  • Published on 6/1/2021

    Standish KR, Gonzalez SC, Roy V, McGuire CM, Barnett KG, Saper RB. Resident Outcomes and Perspectives Over 2 Years of a New Scholarship Curriculum. Fam Med. 2021 Jun; 53(6):461-466. PMID: 34077966.

    Read at: PubMed
  • Published on 1/1/2020

    Roy V. Birch K, Muniesa F (eds.), Assetization: Turning Things into Assets in Technoscientific Capitalism. A Crisis for Cures? Tracing Assetization and Value in Biomedical Innovation. MIT Press. 2020.

  • Published on 1/1/2020

    Roy V. Birch K, Muniesa F (eds.), Assetization: Turning Things into Assets in Technoscientific Capitalism. A Crisis for Cures? Tracing Assetization and Value in Biomedical Innovation. MIT Press. 2020.

  • Published on 1/1/2018

    Mazzucato M, Roy V. Rethinking Value in Health Innovation: From Mystifications Towards Prescriptions. Journal of Economic Policy Reform. 2018; 73(2):1-19.

  • Published on 12/13/2016

    Roy V, Hawksbee L, King L. Factors Influencing Prescription Drug Costs in the United States. JAMA. 2016 12 13; 316(22):2431. PMID: 27959991.

    Read at: PubMed
  • Published on 7/27/2016

    Roy V, King L. Betting on hepatitis C: how financial speculation in drug development influences access to medicines. BMJ. 2016 Jul 27; 354:i3718. PMID: 27815237.

    Read at: PubMed

View all profiles